Caplin Point Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Danyan Capital
Equibles does not estimate personal net worth.
Abhinav is recorded as Analyst at Danyan Capital. Abhinav has spoken on 2 earnings calls across 2 companies, most recently for Caplin Point Laboratories Limited on November 12, 2026. Those appearances were for Caplin Point Laboratories Limited and Share India Securities Limited. The companies whose calls Abhinav spoke on are classified in the Healthcare and Financial Services sectors.
“First time is that in our P.O.L.2 plant, you know, we were first finishing in December 26th, then March 27th, then August 27th now, and I just wanted to know, you know, when can we expect our first revenue here, and how sort of firm is our August 27th deadline, and my second question is on the U.S. you know, TBT…”
“So, we are planning to launch AIF, as I explained. Sir, hi, sir. This is Abhinav. As explained by Sachin Sir earlier in his commentary, AIF is application and the process, and we should be able to initiate our process in Q3 of current system.”
Danyan Capital
Analyst
Transcript header (unverified)
Caplin Point Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Share India Securities Limited
Capital Markets · Financial Services
Earnings Call for the Quarter Ended September 30, 2026
Caplin Point Laboratories Limited
Earnings Call for the Quarter Ended June 30, 2026
Share India Securities Limited